Cybin (TSE:CYBN) has released an update.
Cybin Inc., a leader in neuropsychiatry aiming to transform mental healthcare, announced participation in the H.C. Wainwright 26th Annual Global Investment Conference with CEO Doug Drysdale speaking at events focused on the impact of psychedelics in psychiatry. The live webcast of Drysdale’s fireside chat will be accessible on September 9, 2024, with a panel discussion on mood disorders scheduled for the following day.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
